Tyroserleutide

General Information


DRACP ID  DRACP00145

Peptide Name   Tyroserleutide

Sequence  YSL

Sequence Length  3

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
B16-F10 Mouse melanoma Carcinoma 61.2% cytotoxic at 100 µg/ml MTT assay 96 h 1
BEL-7402 Human papillomavirus-related endocervical adenocarcinoma Carcinoma 39.0% cytotoxic at 0.1 µg/ml MTT assay 96 h 1
BEL-7402 Human papillomavirus-related endocervical adenocarcinoma Carcinoma 20.8% cytotoxic at 1 µg/ml MTT assay 96 h 1
BEL-7402 Human papillomavirus-related endocervical adenocarcinoma Carcinoma 33.8% cytotoxic at 10 µg/ml MTT assay 96 h 1
BEL-7402 Human papillomavirus-related endocervical adenocarcinoma Carcinoma 35.6% cytotoxic at 100 µg/ml MTT assay 96 h 1
B16-F10 Mouse melanoma Carcinoma 49.4% cytotoxic at 0.1 µg/ml MTT assay 96 h 1
B16-F10 Mouse melanoma Carcinoma 51.2% cytotoxic at 1 µg/ml MTT assay 96 h 1
B16-F10 Mouse melanoma Carcinoma 53.0% cytotoxic at 10 µg/ml MTT assay 96 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Enhances the antitumor effects of macrophages and stimulates macrophage secretion of IL-1β, TNF-α, and NO in vitro

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00145

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C18H27N3O6

Absent amino acids  ACDEFGHIKMNPQRTVW

Common amino acids  LSY

Mass  41728

Pl  6.09

Basic residues  0

Acidic residues  0

Hydrophobic residues  1

Net charge  0

Boman Index  138

Hydrophobicity  56.67

Aliphatic Index  130

Half Life 
  Mammalian: >20 hour
  Yeast: >20 hour
  E.coli: ?

Extinction Coefficient cystines  1490

Absorbance 280nm  745

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 16091933

Title  Tripeptide tyroserleutide enhances the antitumor effects of macrophages and stimulates macrophage secretion of IL-1beta, TNF-alpha, and NO in vitro

Doi 10.1007/s00262-005-0024-10

Year  2006

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.